Oral candidiasis is an opportunistic infection usually related to predisposing factors. Oral
manifestations in patients affected by COVID-19 have been reported, as the oral mucosa is …

Luliconazole (LCZ) is a topical imidazole antifungal agent with broad-spectrum activity.
However, LCZ encounters challenges such as low aqueous solubility, skin retention, and …

The efficacy of different echinocandins is assessed by evaluating the in vitro activity of a
novel antifungal, rezafungin, against invasive fungal isolates in comparison with …

Candida albicans remains the most common agent of candidiasis worldwide. This yeast is
generally sensitive to most antifungals, however, the emergence of azole-resistant C …

Background: Different studies have shown that despite the expanding number of antifungal
drugs, the death rate caused by Candida species has increased during the recent decades …

Luliconazole (LCZ) is a topical imidazole antifungal agent with broad-spectrum activity.
However, LCZ faces challenges like low aqueous solubility, skin retention, and penetration …

Background: Among the most frequently recognized pathogenic fungi, Candida spp. from
Clinical samples plays a vital role. In recent decades, poor antifungal therapy usage critically …